Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound.

Eli Lilly said its other insulin products — like Humalog and Insulin ... over their usual vials to contact their health care provider. Those struggling to get the alternate product covered ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity ... its stake in British over-the-counter health-care products purveyor Haleon. The largest pharmacy-benefit ...

Ricks, Lilly chair and CEO. "The rest of our medicines performed within our expectations." "2024 was a pivotal and highly successful year for Lilly, and we expect to continue our momentum in 2025 ...

Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...

Jan 14 (Reuters) - Eli Lilly's (LLY.N), opens new tab stock tumbled ... backs off contesting Tennessee ban on youth transgender care at Supreme Court February 7, 2025 United Statescategory Trump ...

The resources are part of a nationwide collaboration between Lilly and the ADA to destigmatize obesity and encourage stigma-free obesity care. "It's time to recognize obesity as the disease it is.